Residential Aged Care Antibiogram Jan - Dec 2016 Residential Aged Care Antibiogram Jan - Dec 2016

Size: px
Start display at page:

Download "Residential Aged Care Antibiogram Jan - Dec 2016 Residential Aged Care Antibiogram Jan - Dec 2016"

Transcription

1 Residetial Aged Care Atibiogram Ja - Dec 2016 Residetial Aged Care Atibiogram Ja - Dec 2016 Page: 1

2 Cumulative atibiograms specific for idividual health care facilities ca be a useful resource for local atimicrobial stewardship groups to iform empirical therapy recommedatios ad formulary maagemet. The provisio of yearly atibiograms by health care facilities is ow required i the Natioal Safety ad Quality Health Service (NS&QHS) Stadard 3 (3.14.3).¹ This documet cotais the yearly cumulative atibiogram for your Residetial Aged Care Facility (RACF). It is divided ito three parts 1. Uriary Atibiogram 2. No Uriary Atibiogram 3. Blood Culture Atibiogram (this is a subset of the No Uriary Atibiogram but oly provided if sufficiet data is available). Orgaisms are listed i descedig order of frequecy. Orgaisms are colour coded accordig to whether they are Gram or Gram Negative orgaisms. Oly the first isolate of a give species per patiet per year per subtype (e.g urie, o urie, blood cultures) is icluded. Screeig isolates collected for ifectio cotrol purposes have bee removed. Sice 2012, susceptibility testig to produce these atibiograms is performed usig EUCAST microbroth dilutio ad disc diffusio.² Expert EUCAST rules i Atimicrobial Susceptibility testig have bee applied.³ Residetial Aged Care Atibiogram Ja - Dec 2016 Where the total umber of isolates tested is < 30, results are cosidered statistically ivalid i accordace with CLSI M39-A2⁴ ad have therefore ot bee icluded. Where oly a subset (< 95%) of isolates from a particular orgaism group have bee tested, reported susceptibilities are usually ot idicative of the true susceptibility because of the selective ature of testig oly more resistat isolates. These occasios are marked with a * ad susceptibility results should be iterpreted with cautio. The % susceptibility has ot bee colour coded. Sigal resistaces: At the ed of each atibiogram, sigal resistaces are summarised eve if the orgaism occurs at a frequecy too low (< 30) to appear i either the uriary, o-uriary or blood culture atibiograms. These orgaisms iclude Eterobacteriaceae resistat to third or fourth geeratio cephalosporis due to the presece of Exteded Spectrum Beta Lactamases (ESBLs) Eterobacteriaceae resistat to third or fourth geeratio cephalosporis due to the presece of Plasmid Mediated AMPC productio (PAMPs) Eterobacteriaceae resistat to carbapeems due to the presece of a plasmid mediated carbapeamase (CPE) No Eterobacteriaceae (e.g Acietobacter spp; Pseudomoas aerugiosa) resistat to carbapeems due to the presece of a plasmid mediated carbapeamase (CPNE) Vacomyci resistat Eterococci (VRE) Methicilli resistat Staphylococcus aureus (MRSA) Vacomyci itermediate ad vacomyci resistat Staphylococcus aureus (hvisa, VISA, VRSA) Peicilli itermediate ad resistat Streptococcus peumoiae otig that breakpoits differ accordig to cliical coditio (meigitis, peumoia, other) ad mode of admiistratio Peicilli itermediate ad resistat viridas Streptococci Page: 2

3 Colour codig for all atibiograms tables is show below. Residetial Aged Care Atibiogram Ja - Dec 2016 Gram Orgaism Gram Negative Orgaism Atibiotic Not recommeded to be used i childre without specialist advice 90% of isolates susceptible 70-89% of isolates susceptible <70% of isolates susceptible 90% of isolates susceptible (where sample size <95% of total isolates tested) 70-89% of isolates susceptible (where sample size <95% of total isolates tested) <70% of isolates susceptible (where sample size <95% of total isolates tested) Restricted or 2d Lie Atibiotics R Itrisic Resistace is preset with this orgaism-atibiotic combiatio * Sample size <95% of the total isolates tested Restricted or 2d Lie Atibiotics ad Atibiotic Not recommeded to be used i childre without specialist advice % Percetage of isolates sesitive to this partcular atibiotic Number of isolates tested with this atibiotic Refereces: Cliical ad Laboratory Stadards Istitute (CLSI). Guidelie for Aalysis ad Presetatio of Cumulative Atimicrobial Susceptibility (M39-A2). 3rd ed. Pesylvaia: CLSI, Page: 3

4 Residetial Aged Care Atibiogram Ja - Dec 2016 Urie Atibiogram All SNP Nursig Home Orgaisms %Total Amoxycilli Amoxycilli/Clavulaate Ticarcilli/Clavulaate Pipericilli/Tazobactam Cephalexi Ceftriaxoe Ceftazidime Meropeem Getamici Amikaci Trimethoprim Nitrofuratoi Norfloxaci Fusidic Acid Rifampici Getamici (High Level) Fosfomyci Quiupristi/dalfopristi Vacomyci All isolates Escherichia spp % *2648 *226 * *446 *254 *457 * *141 Eterococcus spp % 94 R *21 *21 *22 *52 Klebsiella spp % R *598 *41 * *83 *36 *85 * *18 Pseudomoas aerugiosa Proteus mirabilis Eterobacter cloacae complex Staphylococcus aureus Citrobacter koseri ß haemolytic Streptococci Citrobacter freudii complex % R R R R R 96 * *12 *300 % R *308 *21 * *40 *41 * % R R R *35 *66 *72 *22 *74 * % * *110 *68 *68 *68 % R * % *46 % R R R *14 *21 *20 * Page: 4

5 Residetial Aged Care Atibiogram Ja - Dec 2016 Urie Atibiogram All SNP Nursig Home Orgaisms %Total Amoxycilli Amoxycilli/Clavulaate Ticarcilli/Clavulaate Pipericilli/Tazobactam Cephalexi Ceftriaxoe Ceftazidime Meropeem Getamici Amikaci Trimethoprim Nitrofuratoi Norfloxaci Fusidic Acid Rifampici Getamici (High Level) Fosfomyci Quiupristi/dalfopristi Vacomyci All isolates Coagulase egative Staphylococci Morgaella spp Eterobacter aerogees Miscellaeous GPC % * *55 56 *12 *12 *12 % R R R R 92 *18 *43 * % R R 43 R *14 *14 * % * Page: 5

6 Residetial Aged Care Atibiogram Ja - Dec 2016 Sigal Resistaces: Where the tables below cotai o data o multiresistat orgaisms have bee detected. Urie: Exteded spectrum beta lactamase producig Eterobacteriaceae (ESBL) Orgaism Name % of Strai Citrobacter freudii complex = 70 Citrobacter freudii Eterobacter aerogees = 51 Eterobacter aerogees Eterobacter cloacae complex = 156 Eterobacter cloacae Escherichia spp = 2931 Escherichia coli Klebsiella spp = 638 Klebsiella oxytoca Klebsiella peumoiae Morgaella spp = 52 Morgaella morgaii Proteus mirabilis = 336 Proteus mirabilis Proteus spp other = 16 Proteus vulgaris group Urie: Plasmid mediated AMPC producig Eterobacteriaceae (PAMP) Orgaism Name % of Strai Citrobacter koseri = 81 Citrobacter koseri Escherichia spp = 2931 Escherichia coli Klebsiella spp = 638 Klebsiella oxytoca Klebsiella peumoiae Proteus mirabilis = 336 Proteus mirabilis Proteus spp other = 16 Proteus vulgaris Pseudomoas aerugiosa = 452 Pseudomoas aerugiosa Urie: Plasmid mediated Carbapeemase producig Eterobacteriaceae (CPE) Page: 6

7 Residetial Aged Care Atibiogram Ja - Dec 2016 Orgaism Name % of Strai Eterobacter cloacae complex = 156 Eterobacter cloacae Klebsiella spp = 638 Klebsiella peumoiae Urie: Plasmid mediated Carbapeemase producig No Eterobacteriaceae (CPNE) Orgaism Name % of Strai Urie: Vacomyci Resistat Eterococci (VRE) Orgaism Name % of Strai Eterococcus spp = 742 Eterococcus faecium (VRE) - VAN-A Eterococcus faecium (VRE) - VAN-B Urie: Methicilli Resistat Staphylococcus aureus (MRSA) Orgaism Name % of Strai Staphylococcus aureus = 123 S.aureus (o-multiresistat MRSA) Staphylococcus aureus (MRSA) Staphylococcus aureus (UK EMRSA-15) Page: 7

8 Residetial Aged Care Atibiogram Ja - Dec 2016 No-urie Atibiogram All SNP Nursig Home Orgaisms %Total Peicilli Amoxycilli Flucloxacilli Amoxycilli/Clavulaate Ticarcilli/Clavulaate Pipericilli/Tazobactam Cephalothi Cefazoli Ceftriaxoe Ceftazidime Meropeem Getamici Sulphamethoxazole/Trimethoprim Ciprofloxaci Fusidic Acid Rifampici Erythromyci/Clarithromyci Clidamyci Tetracyclie Vacomyci All isolates Staphylococcus aureus % * *552 * *554 Pseudomoas % R R R R 94 * aerugiosa Haemophilus ifluezae % ß haemolytic % Streptococci Moraxella catarrhalis Escherichia spp % % *12 32 *14 * *11 Page: 8

9 Residetial Aged Care Atibiogram Ja - Dec 2016 Sigal Resistaces: Where the tables below cotai o data o multiresistat orgaisms have bee detected. NoUrie: Exteded spectrum beta lactamase producig Eterobacteriaceae (ESBL) Orgaism Name % of Strai Eterobacter cloacae complex = 7 Eterobacter cloacae Escherichia spp = 35 Escherichia coli Klebsiella spp = 19 Klebsiella peumoiae NoUrie: Plasmid mediated AMPC producig Eterobacteriaceae (PAMP) Orgaism Name % of Strai Escherichia spp = 35 Escherichia coli Klebsiella spp = 19 Klebsiella peumoiae NoUrie: Plasmid mediated Carbapeemase producig Eterobacteriaceae (CPE) Orgaism Name % of Strai NoUrie: Plasmid mediated Carbapeemase producig No Eterobacteriaceae (CPNE) Orgaism Name % of Strai Page: 9

10 NoUrie: Vacomyci Resistat Eterococci (VRE) Residetial Aged Care Atibiogram Ja - Dec 2016 NoUrie: Methicilli Resistat Staphylococcus aureus (MRSA) Orgaism Name % of Strai Staphylococcus aureus = 1825 S.aureus (o-multiresistat MRSA) Staphylococcus aureus (MRSA) Staphylococcus aureus (UK EMRSA-15) NoUrie: Streptococcus peumoiae Peicilli Susceptibility ** (Oral peicilli V breakpoits) MIC category % of Strai Streptococcus peumoiae = 10 Itermediate mg/l Sesitive 0.06 mg/l Page: 10

11 Residetial Aged Care Atibiogram Ja - Dec 2016 Blood Cultures: There are o isolates where is 30 or greater. Sigal Resistaces: Where the tables below cotai o data o multiresistat orgaisms have bee detected. Blood Culture: Exteded spectrum beta lactamase producig Eterobacteriaceae (ESBL) Orgaism Name % of Strai Blood Culture: Plasmid mediated AMPC producig Eterobacteriaceae (PAMP) Orgaism Name % of Strai Blood Culture: Plasmid mediated Carbapeemase producig Eterobacteriaceae (CPE) Orgaism Name % of Strai Eterobacter cloacae complex = 156 Eterobacter cloacae Klebsiella spp = 638 Klebsiella peumoiae Blood Culture: Plasmid mediated Carbapeemase producig No Eterobacteriaceae (CPNE) Orgaism Name % of Strai Page: 11

12 Residetial Aged Care Atibiogram Ja - Dec 2016 Blood Culture: Vacomyci Resistat Eterococci (VRE) Orgaism Name % of Strai Blood Culture: Methicilli Resistat Staphylococcus aureus (MRSA) Orgaism Name % of Strai Staphylococcus aureus = 1 S.aureus (o-multiresistat MRSA) Page: 12

13 Residetial Aged Care Atibiogram Ja - Dec 2016 Miscellaeous orgaism groupigs detail report. Page: 13

All Hospitals Antibiogram Jan - Dec 2016 All Hospitals Antibiogram Jan - Dec 2016

All Hospitals Antibiogram Jan - Dec 2016 All Hospitals Antibiogram Jan - Dec 2016 All Hospitals Atibiogram Ja - Dec 2016 All Hospitals Atibiogram Ja - Dec 2016 Page: 1 All Hospitals Atibiogram Ja - Dec 2016 Cumulative atibiograms specific for idividual health care facilities ca be a

More information

Community Antibiogram Jan - Dec 2016 Community Antibiogram Jan - Dec 2016

Community Antibiogram Jan - Dec 2016 Community Antibiogram Jan - Dec 2016 Commuity Atibiogram Ja - Dec 2016 Commuity Atibiogram Ja - Dec 2016 Page: 1 Commuity Atibiogram Ja - Dec 2016 Cumulative atibiograms from commuity isolates ca be a useful resource to iform empirical therapy

More information

Evaluation of Current Activities of Fluoroquinolones against Gram-Negative Bacilli Using Centralized In Vitro Testing and Electronic Surveillance

Evaluation of Current Activities of Fluoroquinolones against Gram-Negative Bacilli Using Centralized In Vitro Testing and Electronic Surveillance ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Ja. 2001, p. 267 274 Vol. 45, No. 1 0066-4804/01/$04.00 0 DOI: 10.1128/AAC.45.1.267 274.2001 Copyright 2001, America Society for Microbiology. All Rights Reserved.

More information

ANTIMICROBIAL RESISTANCE OF SHIGELLA SPP ISOLATED FROM DIARRHEAL PATIENTS BETWEEN 1989 AND 1998 IN VIETNAM

ANTIMICROBIAL RESISTANCE OF SHIGELLA SPP ISOLATED FROM DIARRHEAL PATIENTS BETWEEN 1989 AND 1998 IN VIETNAM ANTIMICROBIAL RESISTANCE OF SHIGELLA SPP ISOLATED FROM DIARRHEAL PATIENTS BETWEEN 1989 AND 1998 IN VIETNAM NT Va Ah', PD Cam', A Dalsgaard2 'The Natioal Istitute of Hygiee ad Epidemiology, I Yersi Street,

More information

Infections after Transrectal Prostate Biopsy: Report of Fourteen Cases

Infections after Transrectal Prostate Biopsy: Report of Fourteen Cases 42 Global Joural of Pathology ad Microbiology, 2014, 2, 42-46 Ifectios after Trasrectal Prostate Biopsy: Report of Fourtee Cases Derya Ozturk Egi *, Asuma Ia, Ilkur Erdem, Ipek Talas, Yusuf Beek, Seiha

More information

Cefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010

Cefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010 Cefotaxime Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the European

More information

Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version th September 2010

Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version th September 2010 Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version 1.0 26 th September 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the

More information

INHIBITORS IN MILK: PROBLEMS and METHODS OF DETERMINATION. Joana Šalomskienė KTU Food Institute, Kaunas, Lithuania

INHIBITORS IN MILK: PROBLEMS and METHODS OF DETERMINATION. Joana Šalomskienė KTU Food Institute, Kaunas, Lithuania INHIBITORS IN MILK: PROBLEMS ad METHODS OF DETERMINATION Joaa Šalomskieė KTU Food Istitute, Kauas, Lithuaia mikrobjs@lmai.lt, 837312380 Ihibitors (atimicrobials, atibacterial substaces) i dairy idustry:

More information

American Journal of Infection Control

American Journal of Infection Control America Joural of Ifectio Cotrol 41 (2013) 204-9 Cotets lists available at ScieceDirect America Joural of Ifectio Cotrol America Joural of Ifectio Cotrol joural homepage: www.ajicjoural.org Major article

More information

University of Alberta Hospital Antibiogram for 2007 and 2008 Division of Medical Microbiology Department of Laboratory Medicine and Pathology

University of Alberta Hospital Antibiogram for 2007 and 2008 Division of Medical Microbiology Department of Laboratory Medicine and Pathology University of Alberta Hospital Antibiogram for 2007 and 2008 Division of Medical Microbiology Department of Laboratory Medicine and Pathology This material is supported in part by unrestricted educational

More information

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); July 2014.

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); July 2014. Annual survey of extended-spectrum -lactamase (ESBL)-producing Enterobacteriaceae, 2013 Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research

More information

Expert rules in antimicrobial susceptibility testing: State of the art

Expert rules in antimicrobial susceptibility testing: State of the art Expert rules in antimicrobial susceptibility testing: State of the art ESCMID Postgraduate Education Course Antimicrobial Susceptibility Testing and Surveillance: from Laboratory to Clinic Hospital Universitario

More information

Meningococcal B Prevention Tools for Your Practice

Meningococcal B Prevention Tools for Your Practice Meigococcal B Prevetio Tools for Your Practice NAPNAP MeB Facts for HCPs Fast Facts Although ucommo, MeB is potetially fatal. 1 MeB symptoms progress quickly; death ca occur i 24 hours or less. MeB accouts

More information

Sep Oct Nov Dec Total

Sep Oct Nov Dec Total LB PAGE 2 LB PAGE 3 Sep Oct Nov Dec 2007 2007 2007 2007 Total Repeat Information Total Repeats 35 15 17 9 76 Repeat Rate 6.01% 0.17% 1.12% 0.39% 2.07% Repeat Chemistry 25 0 2 0 27 Repeat Extraction 1 0

More information

Received 30 March 2005; returned 16 June 2005; revised 8 September 2005; accepted 12 September 2005

Received 30 March 2005; returned 16 June 2005; revised 8 September 2005; accepted 12 September 2005 Journal of Antimicrobial Chemotherapy (2005) 56, 1047 1052 doi:10.1093/jac/dki362 Advance Access publication 20 October 2005 Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity,

More information

Mupirocin Rationale for the EUCAST clinical breakpoints, version th July 2010

Mupirocin Rationale for the EUCAST clinical breakpoints, version th July 2010 Mupirocin Rationale for the EUCAST clinical breakpoints, version 1.0 6 th July 2010 Foreword EUCAST The European Committee on Antimicrobial Susceptibility Testing (EUCAST) is organised by the European

More information

Antibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005)

Antibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005) Antibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005) Streptococcus pneumoniae (SP) Blood Culture Isolates Penicillin intermediate Penicillin Cefotaxime 336

More information

Consultation on the Revision of Carbapenem Breakpoints

Consultation on the Revision of Carbapenem Breakpoints Consultation on the Revision of Carbapenem Breakpoints July 2018 Please send comments to the EUCAST Scientific Secretary at jturnidge@gmail.com by September 15. EUCAST revision of carbapenem breakpoints

More information

Modified Early Warning Score Effect in the ICU Patient Population

Modified Early Warning Score Effect in the ICU Patient Population Lehigh Valley Health Network LVHN Scholarly Works Patiet Care Services / Nursig Modified Early Warig Score Effect i the ICU Patiet Populatio Ae Rabert RN, DHA, CCRN, NE-BC Lehigh Valley Health Network,

More information

Why some tests are no longer recommended

Why some tests are no longer recommended 8 th July 2014 Why some tests are no longer recommended Robin A Howe, Cardiff, UK Antimicrobial use in Primary Care Tests that are no longer recommended Burkholderia cepacia complex testing Stenotrophomonas

More information

HUSRES Annual Report 2009 Martti Vaara

HUSRES Annual Report 2009 Martti Vaara HUSRES Annual Report 2009 Martti Vaara www.huslab.fi www.intra.hus.fi Martti Vaara, 2/2010 1 The basis of this HUSRES 2009 report is the HUSLAB/Whonet database 2009, which contains susceptibility data

More information

Antimicrobial Activity and Spectrum of PPI-0903M (T-91825), a Novel Cephalosporin, Tested against a Worldwide Collection of Clinical Strains

Antimicrobial Activity and Spectrum of PPI-0903M (T-91825), a Novel Cephalosporin, Tested against a Worldwide Collection of Clinical Strains ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2005, p. 3501 3512 Vol. 49, No. 8 0066-4804/05/$08.00 0 doi:10.1128/aac.49.8.3501 3512.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved.

More information

This material is supported in part by unrestricted educational grants from: Abbott, Bayer HealthCare, Merck Frosst, Roche Diagnostics, and Wyeth Inc.

This material is supported in part by unrestricted educational grants from: Abbott, Bayer HealthCare, Merck Frosst, Roche Diagnostics, and Wyeth Inc. Division of Medical Microbiology Department of Laboratory Medicine and Pathology University of Alberta Hospital and Stollery Children's Hospital Antibiogram 2006 This material is supported in part by unrestricted

More information

Discussion points CLSI M100 S19 Update. #1 format of tables has changed. #2 non susceptible category

Discussion points CLSI M100 S19 Update. #1 format of tables has changed. #2 non susceptible category Discussion points 2009 CLSI M100 S19 Update Nebraska Public Health Laboratory Changes most important to routine antimicrobial susceptibility testing. Documents available Janet Hindler discussion slide

More information

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable:

Study No.: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives: Primary Outcome/Efficacy Variable: UM27/189/ The study listed may iclude approved ad o-approved uses, formulatios or treatmet regimes. The results reported i ay sigle study may ot reflect the overall results obtaied o studies of a product.

More information

Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011)

Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011) b r a z j i n f e c t d i s. 2 0 1 3;1 7(6):672 681 The Brazilian Journal of INFECTIOUS DISEASES www.elsevier.com/locate/bjid Original article Susceptibility rates in Latin American nations: report from

More information

Chlamydia pneumoniae

Chlamydia pneumoniae Chlamydia peumoiae Assessmet of the microimmuoiluorescece test for atibody detectio ad prevalece studies i adult patiets with respiratory tract ifectio A Ph.D - thesis by Mette Beedse Chlamydia peumoiae

More information

Update on CLSI and EUCAST

Update on CLSI and EUCAST Update on CLSI and EUCAST 1 Completed work» Cephalosporin breakpoints for Enterobacteriaceae ESBL screens MIC versus resistance mechanism» Carbapenem breakpoints for Enterobacteriaceae Modified Hodge Test»

More information

Laboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator

Laboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator Nebraska Public Health Laboratory 2008 CLSI M100-S18 update Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator Agenda Discuss 2008 M100- S18

More information

International Journal of Mathematical Archive-4(3), 2013, Available online through ISSN

International Journal of Mathematical Archive-4(3), 2013, Available online through  ISSN Iteratioal Joural of Mathematical Archive-4(), 201, 72-76 Available olie through www.ijma.ifo ISSN 2229 5046 QUALITY CONTOL OF SEA, BY USING DIFFEENT CHTS V. Vasu 1*, B. Kumara Swamy Achari 2 ad L. Sriivasulu

More information

Autism Awareness Education. April 2018

Autism Awareness Education. April 2018 Autism Awareess Educatio April 2018 What is Autism Autism is a wide-spectrum metal disorder that is talked about every day i health circles, but few really kow all the facts about it. Research cotiues

More information

DIVISION OF ANTIINFECTIVE DRUG PRODUCTS (HFD-520) CLINICAL MICROBIOLOGY REVIEW NDA Date review completed: 15 Jun 05

DIVISION OF ANTIINFECTIVE DRUG PRODUCTS (HFD-520) CLINICAL MICROBIOLOGY REVIEW NDA Date review completed: 15 Jun 05 Date company submitted: 15 Dec 04 Date received by CDER: 15 Dec 04 Reviewer: Fred Marsik, Ph.D. Date assigned: 15 Dec 04 NAME AND ADDRESS OF APPLICANT Wyeth Pharmaceuticals Inc. P.O. Box 8299 Philadelphia,

More information

CAVIWIPES1. Technical Bulletin

CAVIWIPES1. Technical Bulletin CAVIWIPES1 Technical Bulletin CaviWipes1 Disinfecting Towelettes are non-woven disposable towelettes pre-saturated with CaviCide1. CaviWipes 1 are intended for use in health care settings such as hospitals,

More information

Resistance to linezolid in enterococci and staphylococci referred to the national reference laboratory

Resistance to linezolid in enterococci and staphylococci referred to the national reference laboratory Resistance to linezolid in enterococci and staphylococci referred to the national reference laboratory Dr Danièle Meunier, AMRHAI BSAC - Antimicrobial Susceptibility Testing User Days Oxazolidinone Linezolid

More information

M e sotheliom a. a UK nursing and inform ation project. Mavis Robinson Project Manager

M e sotheliom a. a UK nursing and inform ation project. Mavis Robinson Project Manager M e sotheliom a a UK ursig ad iform atio project Mavis Robiso Project Maager Mesotheliom a Mesothelioma is a cacer. It most commoly affects the outer liig of the lugs (the pleura). I over 70% of cases

More information

The role of an AMR reference laboratory

The role of an AMR reference laboratory The role of an AMR reference laboratory Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit Crown copyright Primary purpose: regional AMR threats

More information

Tigecycline activity tested against 26, 474 bloodstream infection isolates: a collection from 6 continents

Tigecycline activity tested against 26, 474 bloodstream infection isolates: a collection from 6 continents Diagnostic Microbiology and Infectious Disease 52 (2005) 181 186 www.elsevier.com/locate/diagmicrobio Tigecycline activity tested against 26, 474 bloodstream infection isolates: a collection from 6 continents

More information

Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 April - 30 June 2014

Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 April - 30 June 2014 Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 April - 3 June 214 1. The cumulative cases report since December 21 and cases report during April to June 214 During 1 April to 3 June

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Hospital Universitario Virgen Macarena, Seville New drugs against MRSA and VRE L. Eduardo López Cortés Seville, 8th July Tedizolid Oxazolidinone Ceftaroline // Ceftobiprole 5 th gen cephalosporin Overview

More information

The emergence and rapid dissemination of. Optimising the duration of antibiotic therapy for ventilator-associated pneumonia. J. Chastre and C.E.

The emergence and rapid dissemination of. Optimising the duration of antibiotic therapy for ventilator-associated pneumonia. J. Chastre and C.E. Eur Respir Rev 27; 16: 13, 4 44 DOI: 1.1183/95918.133 CopyrightßERSJ Ltd 27 Optimisig the duratio of atibiotic therapy for vetiator-associated peumoia J. Chastre ad C.E. Luyt ABSTRACT: Vetiator-associated

More information

d Department of Food 25 Key words: Cronobacter, follow up formula, follow on formula, weaning foods, infant 26 foods

d Department of Food 25 Key words: Cronobacter, follow up formula, follow on formula, weaning foods, infant 26 foods 1 1 2 INTERNATIONAL SURVEY OF CRONOBACTER SAKAZAKII AND OTHER 3 CRONOBACTER SPP. IN FOLLOW UP FORMULAS AND INFANT FOODS. 4 5 6 J. Chap a, P. Jackso 3, R. Siqueira b, N. Gaspar c, C. Quitas c, J. Park d,

More information

ZINEX. Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg

ZINEX. Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg ZINEX Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg Tablets Action Cefuroxime axetil owes its bactericidal activity to the parent compound cefuroxime. Cefuroxime is a well-characterized

More information

Phenotypic detection of ESBLs and carbapenemases

Phenotypic detection of ESBLs and carbapenemases Phenotypic detection of ESBLs and carbapenemases Standardized susceptibility testing residential workshop 2016 Katie Hopkins PhD Clinical Scientist Antimicrobial Resistance and Healthcare Associated Infections

More information

Management of Preschool Recurrent Wheezing and Asthma: A Phenotype-Based Approach

Management of Preschool Recurrent Wheezing and Asthma: A Phenotype-Based Approach Maagemet of Preschool Recurret Wheezig ad Asthma: A Pheotype-Based Approach Leoard B. Bacharier, MD Robert C. Struk Edowed Chair for Lug ad Respiratory Research Professor of Pediatrics & Medicie Cliical

More information

CLINICAL USE OF GLYCOPEPTIDES. Herbert Spapen Intensive Care Department University Hospital Vrije Universiteit Brussel

CLINICAL USE OF GLYCOPEPTIDES. Herbert Spapen Intensive Care Department University Hospital Vrije Universiteit Brussel CLINICAL USE OF GLYCOPEPTIDES Herbert Spapen Intensive Care Department University Hospital Vrije Universiteit Brussel Glycopeptides Natural Vancomycin introduced in 1958 Teicoplanin introduced in Europe

More information

Supplementary Information

Supplementary Information Supplemetary Iformatio Quatitative detectio of itric oxide i exhaled huma breath by extractive electrospray ioizatio mass spectrometry Susu Pa a, Yog Tia b, Mig Li c, Jiuya Zhao d, Lala Zhu d, Wei Zhag

More information

GSK Medicine Study Number: Title: Rationale: Study Period: Objectives: Primary Secondary Indication: Study Investigators/Centers: Research Methods

GSK Medicine Study Number: Title: Rationale: Study Period: Objectives: Primary Secondary Indication: Study Investigators/Centers: Research Methods The study listed may iclude approved ad o-approved uses, formulatios or treatmet regimes. The results reported i ay sigle study may ot reflect the overall results obtaied o studies of a product. Before

More information

KENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. #

KENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. # Inc. Efficacy: Hospital Disinfection (at ½ ounce per gallon) Kennel Kare SC is bactericidal according to the AOAC Use Dilution Test method on hard inanimate surfaces modified in the presence of 5% organic

More information

Expert rules. for Gram-negatives

Expert rules. for Gram-negatives Academic Perspective in Expert rules Emerging Issues of Resistance in Gram-ve Bacteria for Gram-negatives Trevor Winstanley Sheffield Teaching Hospitals Presented on behalf of David Livermore University

More information

Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital

Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital ISSN: 2319-7706 Volume 3 Number 10 (2014) pp. 474-478 http://www.ijcmas.com Original Research Article Prevalence of Extended Spectrum -Lactamases In E.coli and Klebsiella spp. in a Tertiary Care Hospital

More information

5.1 Description of characteristics of population Bivariate analysis Stratified analysis

5.1 Description of characteristics of population Bivariate analysis Stratified analysis Chapter 5 Results Page umbers 5.1 Descriptio of characteristics of populatio 121-123 5.2 Bivariate aalysis 123-131 5.3 Stratified aalysis 131-133 5.4 Multivariate aalysis 134-135 5.5 Estimatio of Attributable

More information

Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 st January 31 st March 2015

Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 st January 31 st March 2015 Monitoring of Enhanced Surveillance for Severe and Fatal Pneumonia, 1 st January 31 st March 2015 1. The cumulative cases report since December 2010 and cases report during January to March 2015 During

More information

SUPPLEMENTARY MATERIAL

SUPPLEMENTARY MATERIAL SUPPLEMENTARY MATERIAL (A) Further inclusion criteria and categorisation of ICD-10 diagnostic codes Pneumonia: A310 Pulmonary mycobacterial infection A420 Pulmonary actinomycosis A481 Legionnaires' disease

More information

Drug use in Ireland and Northern Ireland

Drug use in Ireland and Northern Ireland Drug use i Irelad ad Norther Irelad Bulleti 7 Alcohol Cosumptio ad Alcohol-Related Harm i Irelad This bulleti presets the mai fidigs o alcohol cosumptio ad alcohol-related harm amog adults i Irelad from

More information

1 Barnes D and Lombardo C (2006) A Profile of Older People s Mental Health Services: Report of Service Mapping 2006, Durham University.

1 Barnes D and Lombardo C (2006) A Profile of Older People s Mental Health Services: Report of Service Mapping 2006, Durham University. The Natioal Audit Office udertook a self-assessmet cesus of Commuity Metal Health Teams for Older People (CMHTs) betwee September ad December 2006. The overall fidigs are preseted i the Natioal Audit Office

More information

Affinity of Doripenem and Comparators to Penicillin-Binding Proteins in Escherichia coli and ACCEPTED

Affinity of Doripenem and Comparators to Penicillin-Binding Proteins in Escherichia coli and ACCEPTED AAC Accepts, published online ahead of print on February 00 Antimicrob. Agents Chemother. doi:./aac.01-0 Copyright 00, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights

More information

DISTRIBUTION AND PROPERTIES OF SPERMATOZOA IN DIFFERENT FRACTIONS OF SPLIT EJACULATES*

DISTRIBUTION AND PROPERTIES OF SPERMATOZOA IN DIFFERENT FRACTIONS OF SPLIT EJACULATES* FERTILITY AND STERILITY Copyright 1972 by The Williams & Wilkis Co. Vol. 23, No.4, April 1972 Prited i U.S.A. DISTRIBUTION AND PROPERTIES OF SPERMATOZOA IN DIFFERENT FRACTIONS OF SPLIT EJACULATES* R. ELIASSON,

More information

Public Health Surveillance for Multi Drug Resistant Organisms in Orange County

Public Health Surveillance for Multi Drug Resistant Organisms in Orange County Public Health Surveillance for Multi Drug Resistant Organisms in Orange County Matt Zahn, MD Medical Director Epidemiology and Assessment Orange County Public Health Antimicrobial Mechanisms of Action

More information

Plantar Pressure Difference: Decision Criteria of Motor Relearning Feedback Insole for Hemiplegic Patients

Plantar Pressure Difference: Decision Criteria of Motor Relearning Feedback Insole for Hemiplegic Patients 22 4th Iteratioal Coferece o Bioiformatics ad Biomedical Techology IPCBEE vol.29 (22) (22) IACSIT Press, Sigapore Platar Pressure Differece: Decisio Criteria of Motor Relearig Feedback Isole for Hemiplegic

More information

Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia

Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia Feb. 2016 THE JAPANESE JOURNAL OF ANTIBIOTICS 69 1 41 41 Surveillance of antimicrobial susceptibility of Enterobacteriaceae pathogens isolated from intensive care units and surgical units in Russia IRINA

More information

Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis

Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis J Antimicrob Chemother 2016; 71: 2563 2568 doi:10.1093/jac/dkw178 Advance Access publication 30 May 2016 Treatment of MDR urinary tract infections with oral fosfomycin: a retrospective analysis Justin

More information

Vancomycin Rationale for the EUCAST clinical breakpoints, version June 2010

Vancomycin Rationale for the EUCAST clinical breakpoints, version June 2010 Vancomycin Rationale for the EUCAST clinical breakpoints, version 2.1 17 June 2010 Introduction The glycopeptides are a class of agents composed of amino acid residues and attached sugars. Glycopeptides

More information

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory CEFTUM TABLETS. Cefuroxime Axetil Tablets IP 125/250/500mg

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory CEFTUM TABLETS. Cefuroxime Axetil Tablets IP 125/250/500mg For the use only of Registered Medical Practitioners or a Hospital or a Laboratory CEFTUM TABLETS Cefuroxime Axetil Tablets IP 125/250/500mg QUALITATIVE AND QUANTITATIVE COMPOSITION CEFTUM TABLETS 125

More information

Chapter 8 Descriptive Statistics

Chapter 8 Descriptive Statistics 8.1 Uivariate aalysis ivolves a sigle variable, for examples, the weight of all the studets i your class. Comparig two thigs, like height ad weight, is bivariate aalysis. (Which we will look at later)

More information

CAVIWIPES. Technical Bulletin

CAVIWIPES. Technical Bulletin CAVIWIPES Technical Bulletin CaviWipes Disinfecting Towelettes are non-woven disposable towelettes pre-saturated with CaviCide. CaviWipes are intended for use in health care settings such as hospitals,

More information

prescription drug Approval No. solution Attached dissolving (Content per kit) Flomoxef sodium 1 g (potency) Sodium chloride 50 mg

prescription drug Approval No. solution Attached dissolving (Content per kit) Flomoxef sodium 1 g (potency) Sodium chloride 50 mg Shioogi & Co., Ltd. Revised: Jue 9 (9th versio) Stadard Commodity Classificatio o. of Japa 87 - Oxacephem atibiotic aget - FLUMARI for Itraveous Ijectio. g FLUMARI for Itraveous Ijectio g FLUMARI Kit for

More information

GSK Medicine: Study Number: Title: Rationale: Study Period: Objectives: Indication: Study Investigators/Centers: Research Methods:

GSK Medicine: Study Number: Title: Rationale: Study Period: Objectives: Indication: Study Investigators/Centers: Research Methods: The study listed may iclude approved ad o-approved uses, mulatios or treatmet regimes. The results reported i ay sigle study may ot reflect the overall results obtaied o studies of a product. Bee prescribig

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Cefixim STADA 100mg/5ml, poeder voor orale suspensie 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5 ml of reconstituted suspension

More information

In Vitro Activity of Ceftazidime-Avibactam Against Isolates. in a Phase 3 Open-label Clinical Trial for Complicated

In Vitro Activity of Ceftazidime-Avibactam Against Isolates. in a Phase 3 Open-label Clinical Trial for Complicated AAC Accepted Manuscript Posted Online 21 November 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.01820-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10

More information

breakpoints, cephalosporins, CLSI, Enterobacteriacae, EUCAST, review Clin Microbiol Infect 2008; 14 (Suppl. 1):

breakpoints, cephalosporins, CLSI, Enterobacteriacae, EUCAST, review Clin Microbiol Infect 2008; 14 (Suppl. 1): REVIEW Breakpoints for intravenously used cephalosporins in Enterobacteriaceae EUCAST and CLSI breakpoints G. Kahlmeter Department of Clinical Microbiology, Central Hospital, Växjö, Sweden ABSTRACT It

More information

VAPREVENT SYSTEM. Evidence-based innovation in oral care

VAPREVENT SYSTEM. Evidence-based innovation in oral care VAPREVENT SYSTEM Evidece-based iovatio i oral care V A P Vetilator Associated Peumoia (VAP) is the secod most commo hospital-acquired ifectio. 1 It is deadlier tha either cetral lie-associated bloodstream

More information

Ceftaroline fosamil, as ceftaroline fosamil monoacetate monohydrate.

Ceftaroline fosamil, as ceftaroline fosamil monoacetate monohydrate. PRODUCT INFORMATION ZINFORO ceftaroline fosamil NAME OF THE MEDICINE Ceftaroline fosamil, as ceftaroline fosamil monoacetate monohydrate. The chemical name of ceftaroline fosamil monoacetate monohydrate

More information

SUPPLEMENTAL TESTING. Tan Thean Yen

SUPPLEMENTAL TESTING. Tan Thean Yen SUPPLEMETAL TESTG Tan Thean Yen To Supplement Definition: add as a supplement to what seems insufficient "supplement your diet" Why supplement? urrent methods don t work well Additional information provided

More information

Guidance on the use of the Title Consultant Psychologist

Guidance on the use of the Title Consultant Psychologist Guidace o the use of the Title Cosultat Psychologist If you have problems readig this documet ad would like it i a differet format, please cotact us with your specific requiremets. Tel: 0116 2254 9568;

More information

NDA Briefing Document Anti-Infective Drugs Advisory Committee 05 December 2014

NDA Briefing Document Anti-Infective Drugs Advisory Committee 05 December 2014 CEFTAZIDIME-AVIBACTAM FOR INJECTION for Treatment of Complicated Intra-abdominal Infection (used in combination with metronidazole), Complicated Urinary Tract Infection including Acute Pyelonephritis,

More information

Spread of carbapenems resistant Enterobacteriaceae in South Africa; report from National Antimicrobial Resistance Reference Laboratory

Spread of carbapenems resistant Enterobacteriaceae in South Africa; report from National Antimicrobial Resistance Reference Laboratory Spread of carbapenems resistant Enterobacteriaceae in South Africa; report from National Antimicrobial Resistance Reference Laboratory Olga Perovic*, Ashika Singh-Moodley, Samantha Iyaloo 5 th November

More information

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Introduction/Background. Research Team.

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Introduction/Background. Research Team. Research Team Early Ambulatio Reduces the Risk of Veous Thromboembolism After Total Kee Replacemet Marily Szekedi, PhD, RN Baafsheh Sadeghi, MD, PhD, School of Medicie, Uiversity of Califoria Davis Patrick

More information

Proficiency Testing Manual

Proficiency Testing Manual Proficiecy Testig Maual cap.org Table of Cotets Surveys & Educatioal Aatomic Pathology Programs Maual 1 Order Cofirmatio, Specime Hadlig, ad Customer Service 3 7 Cofirmatio 3 Regulatory Reportig 3 Biders/Glossaries

More information

RADIESSE Dermal Filler for the Correction of Moderate to Severe Facial Wrinkles and Folds, Such As Nasolabial Folds

RADIESSE Dermal Filler for the Correction of Moderate to Severe Facial Wrinkles and Folds, Such As Nasolabial Folds A PATIENT S GUIDE RADIESSE Dermal Filler for the Correctio of Moderate to Severe Facial Wrikles ad Folds, Such As Nasolabial Folds Read all the iformatio before you are treated with Radiesse dermal filler.

More information

Whether you have a bacterial infection or a viral infection, there are things you can do to help yourself feel better:

Whether you have a bacterial infection or a viral infection, there are things you can do to help yourself feel better: HEALTHPLUS, AN AMERIGROUP COMPANY MakeHealth Happe Vol. 2, 2013 Do I Need Atibiotics? Atibiotics are medicies used to treat bacterial ifectios ad keep them from spreadig. But if a virus makes you sick,

More information

Carbapenem Disks on MacConkey agar as screening methods for the detection of. Carbapenem-Resistant Gram negative rods in stools.

Carbapenem Disks on MacConkey agar as screening methods for the detection of. Carbapenem-Resistant Gram negative rods in stools. JCM Accepts, published online ahead of print on 7 November 2012 J. Clin. Microbiol. doi:10.1128/jcm.02878-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 Carbapenem Disks

More information

Determining the Optimal Carbapenem MIC that Distinguishes Carbapenemase-Producing

Determining the Optimal Carbapenem MIC that Distinguishes Carbapenemase-Producing AAC Accepted Manuscript Posted Online 8 August 2016 Antimicrob. Agents Chemother. doi:10.1128/aac.00838-16 Copyright 2016, American Society for Microbiology. All Rights Reserved. 1 1 2 Determining the

More information

EVALUATION OF METHODS FOR AMPC β-lactamase IN GRAM NEGATIVE CLINICAL ISOLATES FROM TERTIARY CARE HOSPITALS

EVALUATION OF METHODS FOR AMPC β-lactamase IN GRAM NEGATIVE CLINICAL ISOLATES FROM TERTIARY CARE HOSPITALS Indian Journal of Medical Microbiology, (2005) 23 (2):120-124 Brief Communication EVALUATION OF METHODS FOR AMPC β-lactamase IN GRAM NEGATIVE CLINICAL ISOLATES FROM TERTIARY CARE HOSPITALS S Singhal, T

More information

Author: Souha Kanj Andrew Whitelaw Michael J. Dowzicky. To appear in: International Journal of Antimicrobial Agents

Author: Souha Kanj Andrew Whitelaw Michael J. Dowzicky. To appear in: International Journal of Antimicrobial Agents t Title: In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011 Author: Souha Kanj Andrew Whitelaw

More information

Work up of Respiratory & Wound Cultures:

Work up of Respiratory & Wound Cultures: Work up of Respiratory & Wound Cultures: Culture work up 2 Systematic approaches 1 Work up of Respiratory & Wound Cultures Resident flora Colonizing organisms Pathogens 2 Work up of Respiratory & Wound

More information

Mesporin TM. Ceftriaxone sodium. Rapid onset, sustained action, for a broad spectrum of infections

Mesporin TM. Ceftriaxone sodium. Rapid onset, sustained action, for a broad spectrum of infections Ceftriaxone sodium Rapid onset, sustained action, for a broad spectrum of infections 1, 2, 3 Antibiotic with a broad spectrum of activity Broad spectrum of activity against gram-positive* and gram-negative

More information

SURVEILLANCE BLOODSTREAM INFECTIONS IN BELGIAN HOPITALS ( SEP ) RESULTS ANNUAL REPORT data

SURVEILLANCE BLOODSTREAM INFECTIONS IN BELGIAN HOPITALS ( SEP ) RESULTS ANNUAL REPORT data SURVEILLANCE BLOODSTREAM INFECTIONS IN BELGIAN HOPITALS ( SEP ) RESULTS ANNUAL REPORT data 2000-2014 SEP Workgroup Meeting 24 June 2015 Dr. Naïma Hammami Dr. Marie-Laurence Lambert naima.hammami@wiv-isp.be

More information

Cytokine Profile and Correlation to the APACHE III and MPM II Scores in Patients with Sepsis

Cytokine Profile and Correlation to the APACHE III and MPM II Scores in Patients with Sepsis Cytokie Profile ad Correlatio to the APACHE III ad MPM II Scores i Patiets with Sepsis ELISABETH PRESTERL, THOMAS STAUDINGER, MARIA PETTERMANN, ANDREA LASSNIGG, HEINZ BURGMANN, STEFAN WINKLER, MICHAEL

More information

HDV in Greenland. Henrik Krarup, MD, Phd Section of Molecular Diagnostics Aalborg University Hospital Denmark. Aalborg Hospital NORTH DENMARK REGION

HDV in Greenland. Henrik Krarup, MD, Phd Section of Molecular Diagnostics Aalborg University Hospital Denmark. Aalborg Hospital NORTH DENMARK REGION HDV i Greelad Herik Krarup, MD, Phd Sectio of Molecular Diagostics Aalborg Uiversity Hospital Demark Disclosures Noe relevat to this talk Greelad Achorage Greelad DK Populatio i Greelad 56.000 Idigeous

More information

FAROBACT 200 Tablets (Faropenem)

FAROBACT 200 Tablets (Faropenem) Published on: 10 Jul 2014 FAROBACT Tablets (Faropenem) Composition FAROBACT Tablets Each film-coated tablet contains: Faropenem Sodium equivalent to Faropenem... Dosage Form Oral tablet Pharmacology Pharmacodynamics

More information

Academic Perspective in. David Livermore Prof of Medical Microbiology, UEA Lead on Antibiotic resistance PHE

Academic Perspective in. David Livermore Prof of Medical Microbiology, UEA Lead on Antibiotic resistance PHE Academic Perspective in Emerging No, we can t Issues treat of carbapenemase Resistance and ESBL in Gram-ve producers Bacteria based on MIC David Livermore Prof of Medical Microbiology, UEA Lead on Antibiotic

More information

XERAVATM (eravacycline): A Novel Fluorocycline Antibacterial

XERAVATM (eravacycline): A Novel Fluorocycline Antibacterial XERAVATM (eravacycline): A Novel Fluorocycline Antibacterial Matteo Bassetti, MD, PhD Infectious Diseases Division University of Udine and Santa Maria Misericordia University Hospital Udine, Italy Disclosures

More information

DESCRIPTION 1. Composition

DESCRIPTION 1. Composition Shioogi & Co., Ltd. 1 Revised: Jue 2009 (8th versio) Stadard Commodity Classificatio No. of Japa 876133 - Oxacephem atibiotic aget - SHIOMARIN for Itraveous Ijectio 1 g < Latamoxef sodium for ijectio >

More information

IMPAIRED THEOPHYLLINE CLEARANCE IN PATIENTS WITH COR PULMONALE

IMPAIRED THEOPHYLLINE CLEARANCE IN PATIENTS WITH COR PULMONALE Br. J. cli. Pharmac. (1979), 7, 33--37 IMPAIRED THEOPHYLLINE CLEARANCE IN PATIENTS WITH COR PULMONALE N. VICUNA,1 J.L. McNAY,l T.M. LUDDEN2 & H. SCHWERTNER3 'Divisio of Cliical Pharmacology, Departmets

More information

Urinary Tract Infection and Pattern of Antibiotic Sensitivity in Hospitalized Patients with Diabetes Mellitus in Myanmar

Urinary Tract Infection and Pattern of Antibiotic Sensitivity in Hospitalized Patients with Diabetes Mellitus in Myanmar Volume 2 Issue 1 2018 Page 147 to 153 Research Article Archives of Endocrinology and Diabetes Care Urinary Tract Infection and Pattern of Antibiotic Sensitivity in Hospitalized Patients with Diabetes Mellitus

More information

Differentiation of Carbapenemase producing Enterobacteriaceae by Triple disc Test

Differentiation of Carbapenemase producing Enterobacteriaceae by Triple disc Test Original article: Differentiation of Carbapenemase producing Enterobacteriaceae by Triple disc Test Manish Bansal 1, Nitya Vyas 2, Babita Sharma 3, R.K.Maheshwari 4 1PG Resident, 2 Professor, 3 Assistant

More information

13E1X EDTA-2K CLSI Clinical and Laboratory Standards Institute ml ml ml. 2.0 ml / 2.0 ml / 0.

13E1X EDTA-2K CLSI Clinical and Laboratory Standards Institute ml ml ml. 2.0 ml / 2.0 ml / 0. 13E1X8003002 2017 41 1. 10.0 ml 17.0 ml 10.0 ml 2.0 ml / 2. / 2.0 ml / 1500 ml / 1500 ml / 0.1% 0.5% 0.1N 0.25N ADVIA Cetaur ADVIA Cetaur 1. EDTA-2K CLSI Cliical ad Laboratory Stadards Istitute 1 2 2 2

More information

Canward James A Karlowsky PhD, Mel DeCorby MSc, Daryl J Hoban PhD, George G Zhanel PhD

Canward James A Karlowsky PhD, Mel DeCorby MSc, Daryl J Hoban PhD, George G Zhanel PhD Canward 2007 In vitro activities of ceftobiprole and doripenem tested against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens isolated from patients in

More information

One-week Oral Challenge with Penicillin in Diagnosis of Penicillin Allergy

One-week Oral Challenge with Penicillin in Diagnosis of Penicillin Allergy Acta Derm Veereol 2012; 92: 307 312 INVESTIGATIVE REPORT Oe-week Oral Challege with Peicilli i Diagosis of Peicilli Allergy Jai Hjortlud, Charlotte Gotthard Mortz, Per Stahl Skov, Esbe Eller, Joha Millig

More information

Overcoming the PosESBLities of Enterobacteriaceae Resistance

Overcoming the PosESBLities of Enterobacteriaceae Resistance Overcoming the PosESBLities of Enterobacteriaceae Resistance Review of current treatment options Jamie Reed, PharmD Pharmacy Grand Rounds August 28, 2018 Rochester, MN 2018 MFMER slide-1 Disclosure No

More information